Providing neurorehabilitation at home during COVID-19 pandemic using telehealth mediated dtx solution: A clinical feasibility study

Background and Aims: During the outbreak of COVID-19 many outpatient neuro-rehabilitation services were reduced, disrupting the continuum of care. Technology-enhanced home neurorehabilitation was used by clinicians to provide an alternative solution to continue patients' neurorehabilitation with possibility to monitor progress. Methods: 3 Patients were recruited at CHUV outpatient clinic from march 2020 to may 2020 and enrolled in a home neurorehabilitation program using MindMotionTM GO telehealth platform for 4 weeks targeting motor upper limb, trunk, lower limb rehabilitation. Patients were expected to have 4x asynchronous 30-40min training sessions 4x times a week. Therapists prescribed activities and monitored patients' progress through the device. Outcome measures were patients' therapy time on task and adherence;therapist usability and satisfaction, obtained via structured questionnaires and usage metrics. Results: Average time trained per patient: 14.7h (SD: 4.6), Average training per day: 32' (SD: 6.9') Average adherence 72% (SD:15.6). All therapists agreed on: ease of installation of the device at the patient's home, high adherence rates. All Patients agreed on: feeling in control of rehabilitation, would like to continue using the system. Questionnaires: All therapists perceived a clinical value of remote therapy, ease of usability and would like to use the system more frequently Conclusions: This pilot project demonstrated the clinical feasibility of the deployment of the MindMotionTM GO Telerehabilitation to provide 1) advanced technology home neurorehabilitation that can be remotely monitored by the therapist. 2) administration of desired dosage and adherence rehabilitation services. 3) integration of telerehabilitation in conventional therapies.